Diametric Capital, LP
- SEC CIK
- 0001719087
- Latest filing
- Aug 14, 2026
STLN holding history
Starling Oncology, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STLN overviewAll 13F holders of STLNFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −42,945−100.0% | Sold out | Holders |
| Q3 2025 | 42,945 | $149.9K | 0.1% | +42,945 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −22,201−100.0% | Sold out | Holders |
| Q1 2024 | 22,201 | $35.1K | <0.1% | −35,894−61.8% | Reduced | Holders |
| Q4 2023 | 58,095 | $118.5K | 0.1% | −97,249−62.6% | Reduced | Holders |
| Q3 2023 | 155,344 | $217.5K | 0.1% | +26,952+21.0% | Added | Holders |
| Q2 2023 | 128,392 | $70.6K | <0.1% | +128,392 | New | Holders |